No Fentanyl on Social Media Act
- Bill Number
- S. 3618
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Commerce
- Status
- Introduced
- Latest Action
- 2026-04-14: Committee on Commerce, Science, and Transportation. Ordered to be reported with amendments favorably.
- Last Updated
- 2026-06-23T15:20:24Z
AI-Generated Summary
Purpose
The "No Fentanyl on Social Media Act" aims to investigate and address the risks of minors accessing fentanyl—a highly dangerous opioid drug—through social media platforms. It requires a detailed federal report to Congress to highlight these dangers and recommend ways to prevent them, focusing on protecting children under 18 from illegal drug exposure online.
Key Provisions
- Report Requirement: Within one year of the bill's enactment, the Federal Trade Commission (FTC), in coordination with the Secretary of Health and Human Services (through the Food and Drug Administration) and the Drug Enforcement Administration (DEA), must submit a report to specific congressional committees (House Energy and Commerce Committee and Senate Commerce, Science, and Transportation Committee). The report must also be publicly available on the FTC's website.
- Report Contents:
- How common it is for minors to access fentanyl (including fake pills) from drug sellers on social media.
- Health and safety risks to minors from this access.
- Methods used by drug sellers to advertise, sell, deliver, or distribute fentanyl to minors via social media.
- How social media features (like algorithms or user interfaces) make it easier for minors to encounter fentanyl-related content.
- Current policies and actions by social media companies to stop drug sales, and how effective they are.
- Efforts by law enforcement, doctors, and others to tackle these issues.
- Recommendations for Congress to reduce or eliminate minors' access to fentanyl on social media.
- Consultation Process: The FTC must gather input from stakeholders, including parents, social media companies, law enforcement, medical experts, and others.
- Redaction Option: The FTC, with input from the Attorney General, can remove sensitive details from the report if they might reveal law enforcement strategies.
- Definitions:
- Fentanyl: Includes the drug itself, its chemical analogs (similar versions), and related substances as defined under federal drug laws.
- Minor: Anyone under 18 years old.
- Social Media Platform: Public websites or apps (like social networks or video-sharing services) that host user-generated content (e.g., posts, videos, images). Excludes internet service providers and email services.
Significant Changes to Existing Law
This bill introduces a new federal reporting mandate, with no direct amendments to prior laws. It builds on existing drug control statutes (like the Controlled Substances Act) by focusing specifically on social media's role in fentanyl distribution to minors, but it does not create new enforcement powers or penalties at this stage—it's primarily investigative.
Potential Impacts
- Government Agencies: The FTC, HHS, and DEA will need to allocate resources for research, coordination, and report production, potentially straining budgets but informing future policy. Congress may use the report to develop stronger regulations.
- Citizens: Minors and families could benefit from increased awareness and eventual safeguards against online drug exposure, reducing overdose risks in the ongoing opioid crisis. Parents may gain tools to better monitor children's social media use.
- Social Media Platforms: Companies may face heightened scrutiny, prompting voluntary improvements in content moderation or age verification to avoid future liability.
- International Relations: No direct impacts, though the report could influence global discussions on online drug trafficking if shared internationally.
Main Stakeholders Affected
- Minors and Parents: Primary beneficiaries, as the bill targets protections against fentanyl access, which poses severe health risks like overdose and death.
- Social Media Companies: Directly examined for their platforms' role; they must provide input and may need to adjust practices.
- Drug Sellers and Traffickers: Indirectly targeted, as the report could lead to tougher crackdowns on their online activities.
- Law Enforcement and Medical Professionals: Involved in consultations and highlighted for their anti-drug efforts; the report may recommend more resources for them.
- Federal Agencies (FTC, HHS, DEA): Responsible for producing the report, affecting their workloads.
- Congress: Receives the report to guide potential new laws.
Notable Legal, Constitutional, or Political Implications
- Legal: Establishes a clear federal role in monitoring social media for drug-related harms without immediately imposing fines or bans, potentially setting the stage for expanded FTC authority over online platforms under consumer protection laws.
- Constitutional: Raises questions about balancing free speech (protected under the First Amendment) with child safety, as social media content moderation could be scrutinized; however, the bill's focus on reporting avoids direct censorship.
- Political: Bipartisan support (introduced by senators from both parties) underscores the opioid crisis as a non-partisan issue, emphasizing youth protection. It could spark debates on tech regulation versus innovation, influencing election-year discussions on public health and online safety.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (5)
Sen. Klobuchar, Amy [D-MN], Sen. Blunt Rochester, Lisa [D-DE], Sen. Cassidy, Bill [R-LA], Sen. Moreno, Bernie [R-OH], Sen. McCormick, David [R-PA]
Recent Actions
- 2026-04-14: Committee on Commerce, Science, and Transportation. Ordered to be reported with amendments favorably.
- 2026-01-13: Read twice and referred to the Committee on Commerce, Science, and Transportation.
- 2026-01-13: Introduced in Senate
Bill Versions
- No Fentanyl on Social Media Act — issued 2026-01-13 — PDF (5 pages)